Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Biorxiv : the Preprint Server for Biology|February 16, 2022
SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19Carolin M Lieber, Robert M Cox, Julien Sourimant, et al.Journal of Virology|August 29, 2024
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.Biorxiv : the Preprint Server for Biology|June 3, 2024
Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infectionCarolin M Lieber, Hae-Ji Kang, Elizabeth B Sobolik, et al.Nature Communications|July 29, 2022
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster modelCarolin M Lieber, Robert M Cox, Julien Sourimant, et al.Nature Communications|August 7, 2023
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal modelsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.Science (New York, N.Y.)|December 2, 2021
4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.Biorxiv : the Preprint Server for Biology|December 1, 2022
Paxlovid-like nirmatrelvir/ritonavir fails to block SARS-CoV-2 transmission in ferretsRobert M Cox, Carolin M Lieber, Josef D Wolf, et al.Biorxiv : the Preprint Server for Biology|May 25, 2021
4'-Fluorouridine is a broad-spectrum orally efficacious antiviral blocking respiratory syncytial virus and SARS-CoV-2 replicationJulien Sourimant, Carolin M Lieber, Megha Aggarwal, et al.Science Advances|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.Nature Communications|November 6, 2021
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferretsRobert M Cox, Josef D Wolf, Carolin M Lieber, et al.Pageof 3